Article
The inflammation-resolution promoting molecule resolvin-D1 prevents atrial proarrhythmic remodelling in experimental right heart disease.
Cardiovascular research - 16 Jun 2021
Hiram Roddy, Xiong Feng, Naud Patrice, Xiao Jiening, Sirois Martin, Tanguay Jean-François, Tardif Jean-Claude, Nattel Stanley
Abstract excerpt
AIMS: Inflammation plays a role in atrial fibrillation (AF), but classical anti-inflammatory molecules are ineffective. Recent evidence suggests that failure of inflammation-resolution causes persistent inflammatory signalling and that a novel drug-family called resolvins promotes inflammation-resolution. Right heart disease (RHD) is associated with AF; experimental RHD shows signs of atrial inflammatory-pathway...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
